Versant Capital Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Other funds holding COLL
Versant Capital Management's COLL Position: Q3 2026 in Review
Versant Capital Management reduced its Collegium Pharmaceutical (COLL) stake by 13% in Q3 2026, selling an estimated $6.22K and leaving 1,423 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #1719.
Versant Capital Management first reported a position in COLL in Q1 2020 and has held it in 15 quarters since. The position peaked at $66.9K in Q4 2025. 240 funds tracked by Wall St. Rank hold COLL as of Q3 2026.
- Versant Capital Management held 1,423 shares of Collegium Pharmaceutical worth $31K as of Q3 2026.
- Versant Capital Management sold 213 Collegium Pharmaceutical shares in Q3 2026, an estimated $6.22K.
- Collegium Pharmaceutical made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1719 holding.
- Versant Capital Management first reported a position in Collegium Pharmaceutical in Q1 2020 and has held it in 15 quarters since.
- Versant Capital Management's Collegium Pharmaceutical position peaked at $66.9K in Q4 2025.
- 240 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.